Target intelligence / Profile preview

Ubiquitin specific peptidase 17 like family member 20 (USP17L20)

Target
USP17L20
Molecular classification
Enzyme, Deubiquitinating enzyme, Cysteine protease
01

Overview

Ubiquitin specific peptidase 17 like family member 20 (USP17L20) is a protein-coding gene located on chromosome 4 that encodes a **deubiquitinating enzyme** of the USP family[3][10]. USP17L20 catalyzes the removal of ubiquitin moieties from substrate proteins, modulating their stability, localization, and activity. Through its enzymatic action, it regulates key cellular processes, including cell cycle progression, proliferation, apoptosis, migration, and cellular responses to viral infections[1][10][11]. Genetic studies have associated variation in USP17L20 with a spectrum of immunodeficiency disorders, certain types of obesity, spermatogenic failure, and possibly neurodegenerative conditions such as Alzheimer disease[1]. Despite its functional importance, no drugs are currently documented to specifically target USP17L20.

Other names
Ubiquitin carboxyl-terminal hydrolase 17-like protein 20USP17L20
02

Mechanism of action

For hypothetical inhibitors: inhibition of deubiquitinase activity leading to altered protein ubiquitination status. No specific drugs currently documented.

03

Biological functions

Deubiquitination (removal of ubiquitin from target proteins)Regulation of cell proliferationRegulation of cell cycle progressionRegulation of apoptosisRegulation of cell migrationCellular response to viral infection
04

Disease associations

Immunodeficiency (various subtypes, e.g., immunodeficiency 19, immunodeficiency 73c, common variable immunodeficiency)Combined immunodeficiency with skin granulomasSevere combined immunodeficiency due to IKK2 or LAT deficiencyObesity due to congenital leptin deficiencySpermatogenic failureAlzheimer diseaseOther immune-related or neurodegenerative diseases (possible association)
05

Safety considerations

Potential for immune system dysregulation if targeted, as gene is associated with multiple immunodeficiency syndromesRisk of interference with essential cell cycle and apoptotic processes

Beyond the preview

Go deeper on Ubiquitin specific peptidase 17 like family member 20 (USP17L20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 20 (USP17L20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call